Equities

Biotricity Inc

BTCY:QBB

Biotricity Inc

Actions
  • Price (USD)0.2995
  • Today's Change-0.041 / -11.91%
  • Shares traded383.36k
  • 1 Year change-66.31%
  • Beta1.2046
Data delayed at least 15 minutes, as of Nov 11 2024 20:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.

  • Revenue in USD (TTM)12.24m
  • Net income in USD-18.28m
  • Incorporated2012
  • Employees55.00
  • Location
    Biotricity Inc203 Redwood Parkway, Suite 600REDWOOD CITY 94065United StatesUSA
  • Phone+1 (650) 832-1626
  • Websitehttps://www.biotricity.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Orgenesis Inc662.00k-29.02m5.34m146.00------8.07-8.68-8.680.2005-3.300.027278.295.384,534.25-122.18---1,312.10---101.06---4,489.28--0.0741-5.85-----98.53-50.94-271.82---17.71--
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Aethlon Medical, Inc.0.00-11.50m5.62m14.00--0.6447-----3.87-3.870.000.62510.00----0.00-84.49-76.25-98.84-85.78-------2,246.87----0.00---100.00---1.43------
Agape ATP Corp1.38m-2.45m5.73m21.00--1.78--4.16-0.6396-0.63960.35990.83660.44648.2536.6665,621.91-78.78---111.56--64.23---176.47--4.66--0.0225---22.92---24.61------
Caduceus Software Systems Corp0.00-117.60k5.78m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Optimus Healthcare Services Inc1.89m-7.16m5.94m12.00------3.15-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
Bioelectronics Corp1.61m-289.82k6.18m9.00------3.84-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Biomerica Inc5.51m-6.16m6.56m63.00--1.23--1.19-0.3663-0.36630.32740.31780.52232.633.6987,412.70-58.44-44.68-71.68-51.738.8114.11-111.89-63.822.09--0.00--1.420.810916.27---7.64--
Dalrada Financial Corporation32.16m-21.34m6.79m0.00--0.7687--0.2111-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Neurometrix Inc4.38m-7.94m7.54m26.00--0.4333--1.72-5.50-5.502.918.580.21021.158.53168,600.80-38.06-23.24-40.80-27.2660.1959.17-181.03-48.8810.71--0.00---28.52-18.18-47.84--5.03--
Biotricity Inc12.24m-18.28m7.63m55.00------0.6235-1.74-1.741.18-1.272.121.678.08222,624.00-248.61-269.25----71.8958.93-117.41-258.940.106-0.6408----25.1597.8223.57------
Cutera Inc169.19m-148.97m7.82m430.00------0.0462-7.46-7.468.46-10.730.45722.083.86393,460.50-40.25-22.00-51.64-30.728.1847.63-88.05-27.242.17-31.342.05---15.865.47-97.76--85.87--
Precipio Inc16.72m-3.83m9.04m51.00--0.7399--0.5407-2.68-2.6811.738.240.908917.1216.80327,843.10-20.82-44.98-27.94-58.6839.0828.80-22.90-118.070.590-192.590.0517--61.4639.6252.04--5.37--
Sigyn Therapeutics Inc0.00-3.70m9.15m5.00---------3.08-3.080.00-2.910.00----0.00-1,085.72-493.15-----------10,223.960.0247-2.09---------41.51------
ALR Technologies Inc9.49k-8.00m9.21m6.00------970.95-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Applied DNA Sciences Inc3.40m-7.52m9.64m53.00--0.1587--2.84-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
Data as of Nov 11 2024. Currency figures normalised to Biotricity Inc's reporting currency: US Dollar USD

Institutional shareholders

0.82%Per cent of shares held by top holders
HolderShares% Held
AE Wealth Management LLCas of 30 Jun 202497.75k0.44%
Strengthening Families & Communities LLCas of 30 Sep 202448.26k0.22%
Jane Street Capital LLCas of 30 Jun 202411.64k0.05%
UBS Securities LLCas of 30 Jun 20249.23k0.04%
TD Waterhouse Canada, Inc.as of 30 Jun 20248.00k0.04%
Tower Research Capital LLCas of 30 Jun 20247.72k0.03%
Princeton Global Asset Management LLCas of 30 Sep 2024834.000.00%
RBC Dominion Securities, Inc. (Investment Management)as of 30 Jun 2024501.000.00%
Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024210.000.00%
Osaic Fa, Inc. (Investment Management)as of 30 Jun 2024200.000.00%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.